GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomarin Pharmaceutical Inc (MEX:BMRN) » Definitions » Pretax Margin %

Biomarin Pharmaceutical (MEX:BMRN) Pretax Margin % : 22.70% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Biomarin Pharmaceutical Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Biomarin Pharmaceutical's Pre-Tax Income for the three months ended in Dec. 2024 was MXN3,538 Mil. Biomarin Pharmaceutical's Revenue for the three months ended in Dec. 2024 was MXN15,586 Mil. Therefore, Biomarin Pharmaceutical's pretax margin for the quarter that ended in Dec. 2024 was 22.70%.

The historical rank and industry rank for Biomarin Pharmaceutical's Pretax Margin % or its related term are showing as below:

MEX:BMRN' s Pretax Margin % Range Over the Past 10 Years
Min: -74.41   Med: -3.41   Max: 18.98
Current: 18.98


MEX:BMRN's Pretax Margin % is ranked better than
88.19% of 999 companies
in the Biotechnology industry
Industry Median: -129.77 vs MEX:BMRN: 18.98

Biomarin Pharmaceutical Pretax Margin % Historical Data

The historical data trend for Biomarin Pharmaceutical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomarin Pharmaceutical Pretax Margin % Chart

Biomarin Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.63 -4.08 7.14 7.79 18.98

Biomarin Pharmaceutical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.99 16.27 18.56 18.03 22.70

Competitive Comparison of Biomarin Pharmaceutical's Pretax Margin %

For the Biotechnology subindustry, Biomarin Pharmaceutical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomarin Pharmaceutical's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomarin Pharmaceutical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Biomarin Pharmaceutical's Pretax Margin % falls into.


;
;

Biomarin Pharmaceutical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Biomarin Pharmaceutical's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=11298.847/59520.395
=18.98 %

Biomarin Pharmaceutical's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=3537.94/15585.736
=22.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomarin Pharmaceutical  (MEX:BMRN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Biomarin Pharmaceutical Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Biomarin Pharmaceutical's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomarin Pharmaceutical Business Description

Address
770 Lindaro Street, San Rafael, CA, USA, 94901
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.